The metastases included in this tissue array were gastrointestinal in origin so the performance of ACSL3 and ACSL4 combined biomarker will need to be assessed in relation to other common metastatic tumours such as those arising from lung, breast and melanoma. The gene discussed is ACSL3; the disease is melanoma.